Streetbeat News

Analyst Ratings

MYNZ

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Mainz Biomed (NASDAQ:MYNZ) but lowered the price target from $10 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:43 pm

EXPR

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Express (NYSE:EXPR) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:38 pm

RGS

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Regis (NYSE:RGS) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:34 pm

NKE

A whale investor has taken a bearish stance on Nike (NYSE:NKE), with 61% of the spotted trades being bearish and 38% bullish. The total amount for puts is $600,824 and for calls is $168,228. Whales have been targeting a price range from $90.0 to $107.0 for Nike over the last 3 months. The current price of NKE is down -0.66% at $104.36. Next earnings are expected in 41 days.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 4:16 pm

FDX

A significant bearish stance on FedEx (NYSE:FDX) has been observed through unusual options activity. The sentiment among these big-money traders is 5% bullish and 94% bearish. The whales have been targeting a price range from $210.0 to $280.0 for FedEx over the last 3 months. Currently, the price of FDX is down -0.69% at $263.08. Stephens & Co. downgraded its action to Overweight with a price target of $290.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 4:16 pm

ROST

Guggenheim analyst Robert Drbul has maintained a 'Buy' rating on Ross Stores (NASDAQ:ROST) and raised the price target from $125 to $135.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:10 pm

DDOG

TD Cowen has initiated coverage on Datadog with an Outperform rating, leading to a rise in Datadog's stock price.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:09 pm

CALT

Guggenheim analyst Vamil Divan has maintained a Neutral rating on Calliditas Therapeutics (NASDAQ:CALT) and lowered the price target from $21 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 18, 2023 | 4:08 pm

TSX:WPM

Stifel analyst Ingrid Rico maintains a 'Buy' rating on Wheaton Precious Metals (TSX:WPM) but lowers the price target from C$75 to C$68.

Portfolio Pulse from richadhand@benzinga.com

August 18, 2023 | 4:08 pm